<ul>
 <li>Dietary modification</li>
 <li>MCT supplementation</li>
  <li>Triheptanoin mechanism of action</li>
</ul>

Dietary modification MCT supplementation Triheptanoin mechanism of action

Historical Treatment; Introduction of Triheptanoin

Patients with long-chain fatty oxidation disorders (LC-FAODs) have historically been treated with diet modification and even-carbon medium-chain triglyceride (MCT) supplementation. In this 45-minute, case-based, modular activity, Sandra van Calcar, PhD, RD, LD, and Jerry Vockley, MD, PhD, address key topics, including disease presentation, historical treatment, emerging treatment with triheptanoin, and nutritional planning specific to patients with LC-FAODs.

Share Historical Treatment; Introduction of Triheptanoin

Sign up to save your podcasts

Historical Treatment; Introduction of Triheptanoin

Historical Treatment; Introduction of Triheptanoin